AU562676B2 - Surfactants having pulmonary surface activity - Google Patents

Surfactants having pulmonary surface activity

Info

Publication number
AU562676B2
AU562676B2 AU25125/84A AU2512584A AU562676B2 AU 562676 B2 AU562676 B2 AU 562676B2 AU 25125/84 A AU25125/84 A AU 25125/84A AU 2512584 A AU2512584 A AU 2512584A AU 562676 B2 AU562676 B2 AU 562676B2
Authority
AU
Australia
Prior art keywords
surfactant
surface tension
phosphocholine
dynes
lipoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU25125/84A
Other languages
English (en)
Other versions
AU2512584A (en
Inventor
Masuda Kazuo
Takei Tsunetomo
Kanazawa Yosaku
Tanaka Yuji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tokyo Tanabe Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12518415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU562676(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tokyo Tanabe Co Ltd filed Critical Tokyo Tanabe Co Ltd
Publication of AU2512584A publication Critical patent/AU2512584A/en
Application granted granted Critical
Publication of AU562676B2 publication Critical patent/AU562676B2/en
Assigned to TT PHARMACEUTICALS, INC. reassignment TT PHARMACEUTICALS, INC. Alteration of Name(s) in Register under S187 Assignors: TOKYO TANABE COMPANY LIMITED
Assigned to MITSUBISHI-TOKYO PHARMACEUTICALS, INC. reassignment MITSUBISHI-TOKYO PHARMACEUTICALS, INC. Request to Amend Deed and Register Assignors: TT PHARMACEUTICALS, INC.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
AU25125/84A 1983-03-10 1984-02-28 Surfactants having pulmonary surface activity Expired AU562676B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58038189A JPS59164724A (ja) 1983-03-10 1983-03-10 サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
JP58-38189 1983-10-03

Publications (2)

Publication Number Publication Date
AU2512584A AU2512584A (en) 1984-09-13
AU562676B2 true AU562676B2 (en) 1987-06-18

Family

ID=12518415

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25125/84A Expired AU562676B2 (en) 1983-03-10 1984-02-28 Surfactants having pulmonary surface activity

Country Status (10)

Country Link
US (1) US4603124A (esLanguage)
EP (1) EP0119056B1 (esLanguage)
JP (1) JPS59164724A (esLanguage)
AT (1) ATE55908T1 (esLanguage)
AU (1) AU562676B2 (esLanguage)
CA (1) CA1208129A (esLanguage)
DE (1) DE3483055D1 (esLanguage)
GR (1) GR81930B (esLanguage)
IE (1) IE57006B1 (esLanguage)
MX (1) MX9203493A (esLanguage)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430020A (en) * 1984-12-11 1995-07-04 Scios Nova Inc. Recombinant alveolar surfactant protein
US5110806A (en) * 1985-06-26 1992-05-05 The Regents Of The University Of California Lung surfactant compositions
DE3528934A1 (de) * 1985-08-13 1987-02-26 Feldmuehle Ag Gleitelement aus keramischem werkstoff
EP0240550A4 (en) * 1985-09-26 1989-09-19 Genetics Inst Pulmonary surfactant proteins.
US5256569A (en) * 1986-01-21 1993-10-26 Chisso Corporation Transesterification process for otereoselection of enantiomers of secondary alcohols using pseudomonas lipase with no added solvent
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
US4861756A (en) * 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
US5207220A (en) * 1989-12-12 1993-05-04 Burroughs Wellcome Co. Method for administering pharmaceuticals, including liquid surfactant, to the lungs
FR2658418B1 (fr) * 1990-02-20 1994-09-02 Synthelabo Compositions pharmaceutiques a base de phospholipides.
WO1991017766A1 (fr) * 1990-05-18 1991-11-28 Tokyo Tanabe Company Limited Remede contre l'asthme
US5614216A (en) * 1990-10-17 1997-03-25 The Liposome Company, Inc. Synthetic lung surfactant
JP3961029B2 (ja) * 1992-06-24 2007-08-15 博 木戸 インフルエンザウィルス感染防止剤
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
CO5021218A1 (es) * 1994-12-29 2001-03-27 Ct Nac De Sanidad Agropecuaria Surfactante pulmonar natural porcino
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
CZ292186B6 (cs) 1996-01-24 2003-08-13 Altana Pharma Ag Způsob výroby práškového prostředku s obsahem plicní povrchově aktivní látky, práškový prostředek a jeho použití
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
WO1997035882A1 (en) * 1996-03-27 1997-10-02 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions
US5667948A (en) * 1996-04-16 1997-09-16 Eastman Kodak Company Processing silver halide films with an aqueous phospholipid rinse solution
DE69811407T2 (de) 1997-12-24 2003-11-20 Britannia Pharmaceuticals Ltd., Redhill Verwendung eines oberflächenaktiven mittels zur herstellung eines arzneimittels zur behandlung von erkrankungen des mittelohrs
WO2001019392A1 (en) 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
GB0026239D0 (en) * 2000-10-26 2000-12-13 Britannia Pharmaceuticals Ltd Surface active lipids in treatment of wet lung
US20040241744A1 (en) * 2001-07-12 2004-12-02 Hiroaki Kohno Method of quantifying denatured lipoprotein, reagents for quantifying denatured lipoprotein, method of detecting circulatory disease and reagents for detecting circulatory disease
ES2346048T3 (es) 2001-10-11 2010-10-08 Nycomed Gmbh Nueva utilizacion de un agente tensioactivo pulmonar.
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
CA2575513C (en) 2004-08-06 2014-09-16 Altana Pharma Ag Composition comprising a pulmonary surfactant and a tnf-derived peptide
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
AU2009324637B2 (en) 2008-12-10 2016-09-08 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
NZ607358A (en) 2010-08-23 2015-04-24 Takeda Gmbh Humidified particles comprising a therapeutically active substance
ES2557805T3 (es) * 2012-03-28 2016-01-28 Discovery Laboratories, Inc. Liofilizacion de agente tensioactivo pulmonar liposomico sintetico

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE388023C (de) * 1922-02-14 1924-01-07 Chem Fab Verfahren zur Herstellung von waesserigen Lezithinemulsionen
FR2343481A1 (fr) * 1976-03-11 1977-10-07 Gerlich Norbert Composition destinee a empecher les lesions des membranes biologiques et a regenerer ces membranes une fois qu'elles ont ete endommagees
DE2900300A1 (de) * 1979-01-05 1980-07-17 Lebrecht Von Dr Klitzing Verfahren einer prophylaxe zur vermeidung des atemnotsyndroms bei fruehgeborenen und bei der schocklunge
JPS55160721A (en) * 1979-06-02 1980-12-13 Tokyo Tanabe Co Ltd Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
US4312860A (en) * 1980-10-24 1982-01-26 Regents Of The University Of California Lung surfactant compositions
JPS5845299A (ja) * 1981-09-10 1983-03-16 東京田辺製薬株式会社 新規な表面活性物質、その製造法及びそれを含有する呼吸窮迫疾候群治療剤

Also Published As

Publication number Publication date
EP0119056B1 (en) 1990-08-29
MX9203493A (es) 1992-08-01
EP0119056A3 (en) 1986-06-25
DE3483055D1 (de) 1990-10-04
JPS59164724A (ja) 1984-09-17
JPH0378371B2 (esLanguage) 1991-12-13
AU2512584A (en) 1984-09-13
CA1208129A (en) 1986-07-22
IE57006B1 (en) 1992-03-11
IE840553L (en) 1984-09-10
US4603124A (en) 1986-07-29
EP0119056A2 (en) 1984-09-19
ATE55908T1 (de) 1990-09-15
GR81930B (esLanguage) 1984-12-12

Similar Documents

Publication Publication Date Title
AU2512584A (en) Surfactants having pulmonary surface activity
JPS5799524A (en) Mammal lung surface active drug composition
AU4299689A (en) Biologicaly active lipoprotein and its use
DE3378353D1 (en) Lung surfactant
NZ190924A (en) (dl)-16-phenoxy-9-keto-prostatrienoic acids derivatives and pharmaceutical compositions
DE3886970D1 (de) Natürliches oberflächenwirksames Lungenpräparat, Verfahren zu seiner Herstellung und pharmazeutische Zusammensetzungen.
ATE125251T1 (de) Polyglycerinfettsäureestergemisch.
ATE43244T1 (de) Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung.
Robertson Lung surfactant for replacement therapy
JPS56127308A (en) Blood-coagulation factor 8 pharmaceutical
HARRIS et al. Venous air embolism and cardiac arrest during craniectomy in a supine infant
Brown et al. Effect of nutritional status on the lung surfactant system: food deprivation and caloric restriction
JPS5692217A (en) Easily absorbable enzyme preparation
DE3362256D1 (en) 4-(trans-4'-alkyloxymethylcyclohexyl) benzoic acid esters
IL85403A (en) O-(6-alkoxy-2-t-butyl-pyrimidin-4-yl)-o-methylthionophosphonic acid esters,their preparation and their use as pesticides
DE69132211D1 (de) Synthetische oberflächenaktive agentien auf der lunge
ES2092969A1 (es) Surfactante pulmonar natural de origen porcino.
NO894083L (no) Farmasoeytiske blandinger for behandling av adrenoleukodystrophy.
JPS5795908A (en) Antiallergic agent
EP0090603A3 (en) Antibacterial compounds
ZA899622B (en) Aerosol formulations
JPS5592321A (en) Antilipemic agent
JPS5382760A (en) Novel benzoylphenoxyacetic acid derivs., process for their preparation and lipid lowering agents contg. active constituents
EP0277908A3 (en) 2-(2,2-difluorocyclopropyl)-alkylester, process of preparation and use as insecticide and acaricide
JPS57193428A (en) 2-acyl-6-aminophenol derivative, its preparation, and remedy for diseases caused by leucotriene containing the same

Legal Events

Date Code Title Description
HB Alteration of name in register

Free format text: MITSUBISHI-TOKYO PHARMACEUTICALS, INC.

MK14 Patent ceased section 143(a) (annual fees not paid) or expired